Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
Background: The impact of pregnancy on efavirenz (EFV) pharmacokinetics is unknown. Methods: International Maternal Pediatric Adolescent AIDS Clinical Trials P1026s is an on-going, prospective, nonblinded study of antiretroviral pharmacokinetics in HIV-infected pregnant women that included a cohort...
Saved in:
Main Authors: | Cressey T., Stek A., Capparelli E., Bowonwatanuwong C., Prommas S., Sirivatanapa P., Yuthavisuthi P., Neungton C., Huo Y., Smith E., Best B., Mirochnick M. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859758788&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42883 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
by: Tim R. Cressey, et al.
Published: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
by: Regis Kreitchmann, et al.
Published: (2019) -
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
by: Regis Kreitchmann, et al.
Published: (2018) -
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
by: Regis Kreitchmann, et al.
Published: (2018) -
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
by: Cressey T., et al.
Published: (2017)